Sunlight appears to inactivate the coronavirus which causes COVID-19, according to a study.Scientists found imitation sunlight "rapidly inactivated" SARS-CoV-2 on stainless steel coupons in a lab. The findings were published in The Journal of Infectious Diseases.Past studies have shown that SARS-CoV-2 can linger in the right conditions on non-porous indoor surfaces for days, the authors…
Does sunlight really kill COVID-19? Here's what experts say Does sunlight really kill COVID-19? Here's what experts say With coronavirus cases rising daily, and more and more governments announcing plans to reopen their economies, plans that often require others to wear masks to enter stores, many are wondering how to best keep themselves safe. Ultraviolet…
Not only are artificial ultraviolet techniques ineffective and likely deadly for treating an infected person, scientists say, some of them can be extremely dangerous used at home for disinfecting.“From nurses to some guy building a UVC box in their basement, I’m getting calls every day” asking for help with setup, said Brian Heimbuch, molecular biologist…
A new study from government lab experiments says preliminary results indicate the coronavirus SARS-CoV-2 is quickly destroyed on surfaces by sunlight and does not live long in high temperatures and high humidity.The study, obtained by Yahoo News, “offers hope that summertime may offer conditions less hospitable for the virus, though experts caution it will by…
Robert F. Kennedy Jr. has rightly made “radical transparency” the motto of his Department of Health and Human Services. HHS even has a page by that name. I think it is a good motto, and I want to help Secretary Kennedy and Acting FDA Commissioner Kyle Diamantas deliver on it in food safety, with two citizen petitions
Published: October 30, 2026, 10:16 pm Several reports of children choking have led to an FDA warning against Once Upon A Time snacks. The warning covers all flavors, quantities, lots and dates of Once Upon A Farm Tractor Wheels Organic, Toddler Soft-Baked Bars. The FDA has received several reports that describe infants ages 1.5 to
The FDA has cleared the interleukin (IL)-23 inhibitor tildrakizumab (Ilumya) for the treatment of active psoriatic arthritis (PsA) in adults. Sun Pharma announced the approval on October 30. “As an IL-23 inhibitor administered exclusively by a healthcare provider, Ilumya is now an option for adults with active psoriatic arthritis who are unable to self-administer treatment